MidCap T ApS: Financial statements 2025
CVR: 40238581
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MidCap T ApS (CVR 40238581) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -16,000 and a net result of DKK -24,871,000 compared with DKK 621,000 the year before. Equity in the 2025 report amounted to DKK 173,650,000. The solvency ratio was 98.2%.
- Gross Profit
- DKK -16,000
- Profit/Loss
- DKK -24,871,000
- Equity
- DKK 173,650,000
- Total Assets
- DKK 176,790,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -16 t. | -24.9 mio. | 173.7 mio. | 0 |
| 2024 | - | -109 t. | 621 t. | 198.5 mio. | - |
| 2023 | - | -13 t. | 186 t. | 144.5 mio. | - |
| 2022 | - | -13 t. | -11 t. | 119.3 mio. | - |
| 2021 | - | -19 t. | -35 t. | 119.3 mio. | - |
Official annual report
How creditworthy is MidCap T ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 29, 2025, Thomas Brandhof has joined the board of directors of MidCap T ApS.
MidCap T ApS has published its annual report for 2024. Gross profit came to DKK -109,000, and the net result was DKK 621,000.
As of March 3, 2025, Signe Trock Hilstrøm has joined the board of directors of MidCap T ApS.
As of March 3, 2025, Rasmus Emil Andersen has joined the board of directors of MidCap T ApS.
As of March 3, 2025, Jacob Lachmann has left the board of directors of MidCap T ApS.
As of March 3, 2025, Stig Løkke Pedersen has left the board of directors of MidCap T ApS.
As of March 3, 2025, Dennis Dencher has left the board of directors of MidCap T ApS.
About MidCap T ApS
MidCap T ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Martin Jørgensen. The board consists of Ulrik Kronborg Markussen (chair), Claus Svane Gleerup, Mads Bødtcher-Hansen and Martin Jørgensen. The company's owners include ORIFARM GENERICS HOLDING A/S, MBH ApS and Janus Investering ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,000 and a net result of DKK -24,871,000 compared with DKK 621,000 the year before. Equity in the 2025 report amounted to DKK 173,650,000.